… of bleeding while maintaining anticoagulation and patient … stopping anticoagulation when
VTE was provoked by a major transient risk factor (eg surgery) and prolonging anticoagulant …

… Therefore, it appears safe to discontinue anticoagulant therapy in patients treated with
warfarin for AF, without bridging, if the CHADS 2 score is <4 and/or if there is no history of a prior …

… therapy, alternative anticoagulants) or risk stratification at a … at low risk who can safely
discontinue anticoagulants after 5–… permitted us to identify a low-risk group of men; however, it is …

… risk factors, and the more common and validated factors have been used to formulate risk
stratification … Of the common stroke and bleeding risk schema in use (or recommended in …

… Certainly, risk stratification approaches enable individualised management of unprovoked
VTE. Although there appears to be no clear subgroup of men who can be identified as having …

… , we followed individuals in the large Anticoagulation and Risk Factors in Atrial Fibrillation
(… rates of warfarin discontinuation and clinical risk factors associated with discontinuation. …

… Our material includes data from 2006 through 2012; at this time, both CHADS 2 and CHA 2
DS 2 -VASc were used for stroke risk stratification in patients with AF. Among patients with a …

… of stroke and systemic embolism with OAC discontinuation varied according to CHADS 2 …
between risk and benefit: the risk of stopping OACs, ie cardio-embolic stroke, and the risk of …

… Detailed risk stratifications of recurrent VTE … risk factors included on-going non-malignant
condition associated with at least a 2-fold risk of recurrent VTE after stopping anticoagulation …

… review on risk stratification of endoscopic procedures based on American Society of
Gastrointestinal Endoscopy guideline on the management of anticoagulation and antiplatelet …